학술논문
Recombinant Mycobacterium bovis BCG is a promising platform to develop vaccines against Trypansoma cruzi infection.
Document Type
Article
Author
Source
Clinical & Experimental Immunology; Sep2020, Vol. 201 Issue 3, p306-316, 11p, 1 Diagram, 3 Charts, 4 Graphs
Subject
Language
ISSN
00099104
Abstract
Copyright of Clinical & Experimental Immunology is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)